PHARMA ENGINEERING LIMITED Financials
- Company number
- 06090111CopyCopy
- Registered office
- Unit 66 Sandford Lane Industrial Estate Sandford Lane, Kennington, Oxford, Oxfordshire OX1 5RP
- Incorporated
- 07/02/2007
Company snapshot
- Status
- Active
- Employees
- 8 (2024)
- Latest financial data
- 2024
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2024.
Net Assets
20.11%vs 20232023: £1.49M
Total Assets
10.76%vs 20232023: £1.80M
Cash in Bank
26.84%vs 20232023: £805.49K
Total Liabilities
-39.47%vs 20232023: £275.34K
Employees
+1vs 20232023: 7
In 2024, PHARMA ENGINEERING LIMITED reported net assets of £1.79M. The same filing shows total assets of £1.99M, cash in bank of £1.02M and total liabilities of £166.67K. Reported headcount was 8 in 2024. Net Assets rose from £1.49M in 2023 to £1.79M in 2024 (20.11%). Okredo holds filed figures for 2021–2024; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
20.11%from £1.49M in 2023Year-on-year change
Net Assets as filed for 2021–2024. Every figure in this chart is also in the financial history table.
3-year financial trend (2022–2024)
How the figures PHARMA ENGINEERING LIMITED filed moved across the three reported years 2022, 2023 and 2024 — measured end to end rather than year on year.
Net Assets
+54.3%vs 2022+24.2% a year compound (CAGR)
Cash in Bank
+64.4%vs 2022+28.2% a year compound (CAGR)
Total Assets
+15.5%vs 2022+7.5% a year compound (CAGR)
Total Liabilities
-69.4%vs 2022-44.7% a year compound (CAGR)
Employees
+33.3%vs 2022+2Biggest increase
Cash in Bank+64.4%
£621.63K in 2022 to £1.02M in 2024
Biggest decrease
Total Liabilities-69.4%
£544.30K in 2022 to £166.67K in 2024
PHARMA ENGINEERING LIMITED's filings pull in both directions between 2022 and 2024. The steepest rise came in cash in bank, pointing to a more liquid cash position, set against a fall in total liabilities, pointing to lighter outstanding obligations. See the full year-by-year figures.
Ratios from the filed figures
Calculated from PHARMA ENGINEERING LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 90.07%2024
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 8.38%2024
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 613.01%2024
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 51.35%2024
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for PHARMA ENGINEERING LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Net Assets£ | 737.19K | 1.16M | 1.49M | 1.79M |
| Total Assets£ | 1.53M | 1.72M | 1.80M | 1.99M |
| Cash in Bank£ | 455.93K | 621.63K | 805.49K | 1.02M |
| Total Liabilities£ | 770.95K | 544.30K | 275.34K | 166.67K |
| Employees | 7 | 6 | 7 | 8 |
PHARMA ENGINEERING LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for PHARMA ENGINEERING LIMITED covering 2021–2024, across 5 reported indicators. The most recent reported year is 2024.
PHARMA ENGINEERING LIMITED reported net assets of £1.79M for 2024. That compares with £1.49M in 2023, a change of 20.11%.
PHARMA ENGINEERING LIMITED reported total assets of £1.99M for 2024. That compares with £1.80M in 2023, a change of 10.76%.
PHARMA ENGINEERING LIMITED reported cash in bank of £1.02M for 2024. That compares with £805.49K in 2023, a change of 26.84%.
PHARMA ENGINEERING LIMITED reported 8 employees in 2024, compared with 7 in 2023.
Between 2022 and 2024, PHARMA ENGINEERING LIMITED's net assets rose by 54.3%, cash in bank rose by 64.4%, total assets rose by 15.5% and total liabilities fell by 69.4%. Net assets compounded at 24.2% a year across the two years to 2024, from £1.16M to £1.79M. Reported headcount went from 6 in 2022 to 8 in 2024 (+2).
Okredo holds reported figures for the years 2021, 2022, 2023, 2024. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.